Empowered Patients: Redefining Healthcare

In recent years, the healthcare landscape has experienced significant transformations, largely driven by technological advancements that empower patients to take a more active role in managing their health. The statistics reflect this shift:

Wearable Health Devices

• Market Growth: The global market for wearable medical devices was valued at approximately $24 billion in 2023 and is projected to reach $72.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.8%.

• Consumer Adoption: A survey revealed that 80% of consumers own at least one personal medical device, such as blood pressure monitors, electric toothbrushes, or fitness trackers. Notably, 28% of users have received alerts for potential health issues from these devices, and 84% found this data valuable.

  
  

Telemedicine

• Market Expansion: The medical devices market, encompassing telemedicine platforms, was valued at $810.4 billion in 2024 and is projected to reach $1.29 trillion by 2029, reflecting a CAGR of 9.8%.

  
  

Personalized Health Tools

• Digital Health Market: The global digital health market was valued at $240.85 billion in 2023 and is projected to reach approximately $1,635.11 billion by 2033, indicating substantial growth in personalized health tools and services.

  
  

Defender Leads Way in Empowering Patients  with Diabetic Foot Ulcers

Defender, a medical device company specializing in protecting at-risk feet and lower extremities, is transforming diabetic foot ulcer (DFU) care with its AI-powered disease management platform. The DFU Patient Platform supports patients through all stages, from wound healing to prevention, while encouraging active participation in their care. Defender has partnered with AlexiGen, Anderson Medical Supplies, and Sensoria to enhance patient support, solidifying its leadership in DFU care. Recognized as the "new standard of care," Foot Defender is utilized in over 10 clinical trials, including the NIH RO1 study, the DFU "smart boot" trial, and LifeNet Health initiatives.

These developments underscore a significant shift toward patient empowerment, with technology playing a pivotal role in enabling individuals to manage their health proactively and collaboratively.

Please contact Tony Coretto for more information or to arrange a meeting with Jason.

We are pleased to announce that we have recently joined ZS2 as equity partners and advisors, to support their financing and fundraising efforts in the United States. ZS2 is a leader in developing magnesium cement technology aimed at decarbonizing the construction industry while providing products that have superior strength and fire retardance. The Company develops, manufactures, and commercializes advanced low-carbon building technologies. By utilizing industrial by-products and captured CO₂ in their production processes, ZS2 offers an innovative, climate-responsive alternative to traditional cement.

Please contact Mitchell Hauser or Tony Coretto for further information or to arrange a meeting with Scott Jenkins, ZS2's CEO.

Nanocrine is a life sciences technology company applying nanotechnology to biosensing. With technology licensed from the US Naval Research Laboratory, Nanocrine's Plasmonic Chip allows scientists to see and measure, in real time, exactly how cells communicate by releasing and absorbing proteins in the “dark space” between them.

Recent updates include:

• As 2025 launches, Nanocrine has begun this new year by rapidly transitioning from their research stage into commercial operations. Several important laboratories, including the National Institutes of Health and a California-based biotechnology company, have placed first orders for our revolutionary live cell profiling biochips

• Nanocrine has successfully closed their bridge round, and initiated their planned institutional round

  
  

Please contact Mitchell Hauser for more information or to arrange a meeting with Patrick Calhoun, Nanocrine's President and Chief Science Officer.

ReCarbon is a leading greenhouse gas (GHG) utilization company; with their proprietary technologies, the company converts GHG into carbon-negative syngas, hydrogen, methanol, and other clean fuels safely and efficiently.

New updates include:

• ReCarbon is exploring the development of sites in California and the Southeast US for producing renewable methanol with Portugal-based Capwatt, for sale at a major US port

• Progress continues on finalizing the lease and supply agreement for the City of Lancaster/LACSD Hydrogen Project (Antelope Valley Circular Hydrogen Initiative), with ReCarbon engaging a contractor to survey the PCCU (Plasma Carbon Conversion Unit) and related equipment site, as required for the final agreement

  
  

Please contact Mitchell Hauser or Soojin Choung for further information or to arrange a meeting with Jay Kim, PhD, ReCarbon's Founder & CEO.

AKOS has reached a major milestone with the arrival of its 3rd generation base tool in Red Deer, Alberta and performed a successful function test. AKOS now has several well operators asking to schedule a first job and we anticipate the first job to be performed next week with a MLT day rates of $25K CAD. After running the base tool in a few wells, AKOS will mobilize its Multilateral Navigation tool to Canada and begin intervention work on the multilateral wells (under the agreements already in place) with local well operating companies.

AKOS’ advanced, proprietary well intervention and drilling services deliver significantly improved (1.4Mmt of CO2 reduction as of direct result of AKOS' Cybercoil services in 2028 and enable 90Mmt of CO2 reduction in 2028) sustainability, reduced environmental impact, and far superior economics to operating companies in the energy sector. 

Please contact Mitchell Hauser for more information or to arrange a meeting with Kent Kalar, AKOS' CEO. 

Splash, the leader in sustainable automated carwashes in China (the world’s largest market), has made significant progress toward its expansion goals for 2025:

• On January 9th, Splash signed a US $4.1M development financing deal with Shanghai Chao Gu Investment Co. Under this facility Chao Gu will finance 100% of the development costs for 75 new Splash Express locations

• Splash’s latest seed round of US $1.5M will be closing in Q1'25. Post financing, Splash will focus exclusively on new site development until the launch of a Series A financing in Q1’26

• Hydrocycle (Splash's water recycling subsidiary) has confirmed its US $345K first phase order with Romania’s largest medical waste processing company, for facilities in both Romania and Moldova

• Hydrocycle has also confirmed an agreement with an established waste treatment company based in Manila that will act as the company’s distributor for the Philippine market

  
  

For further information or to set up time to speak with Splash's CEO, Rob Shesol, please contact Tony Coretto.

Tony Coretto, Managing Director at Strategic Ventures, singing Christmas carols and spreading holiday cheer in Woodstock, New York.